Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antifungal Susceptibility
48%
Fungi
43%
Species Complex
30%
Amphotericin B
30%
Candida Auris
29%
Genotype
28%
Aurès
27%
Fusarium
26%
Itraconazole
24%
Voriconazole
22%
Fluconazole
20%
Cryptococcus Neoformans
18%
Cryptococcosis
17%
Sporothrix
17%
Quantitative PCR
17%
Brazil
16%
Epidemiology
16%
Sporothrix Species
16%
Neoformans
15%
Molecular Epidemiology
14%
Chromoblastomycosis
14%
Antifungal Therapy
14%
Gattii
14%
Posaconazole
14%
Fumigatus
14%
Sporotrichosis
13%
Paracoccidioidomycosis
13%
Amplified Fragment Length Polymorphism
13%
Candidemia
13%
Clinically Significant
13%
Immunocompromised Patients
13%
Mucormycosis
13%
Iran
12%
Candida
12%
Candida Parapsilosis
12%
Invasive Pulmonary Aspergillosis
12%
Yeast-like
12%
International Guidelines
12%
Candida Albicans (C. albicans)
11%
Yeast Species
11%
Genetic Diversity
11%
Cryptococcus Gattii Species Complex
11%
Internal Transcribed Spacer 1 (ITS1)
10%
Fusarium Species
10%
Antifungal Agents
10%
Minimum Inhibitory Concentration
10%
Molecular Characterization
10%
ISHAM
10%
Cryptococcus
10%
Dermatophytes
10%
Isavuconazole
10%
Azole Resistance
9%
Aspergillus
9%
Antifungal Resistance
9%
Aspergillus Fumigatus
9%
Trichophyton Rubrum
9%
Paracoccidioides
9%
Trichosporon
9%
Melanized Fungi
9%
Fungal Pathogens
9%
Species Identification
9%
China
9%
Etiological Agent
9%
C. Parapsilosis
9%
S. Brasiliensis
9%
Fungal PCR
9%
Fungal Infection
8%
Keratitis
8%
Environmental Sources
8%
Amplified Fragment Length Polymorphism Fingerprinting
8%
Histoplasmosis
8%
Fluconazole Resistance
8%
Blood Isolates
8%
Polymerase Chain Reaction
8%
Microsatellite Typing
8%
Black Yeast
8%
Micafungin
8%
Candida Species
8%
Amplified Fragment Length Polymorphism Markers
8%
Virulence
8%
Caspofungin
8%
COVID-19
8%
Molecular Identification
8%
Cystic Fibrosis
8%
Genotypic Diversity
7%
Terbinafine
7%
Environmental Isolates
7%
In Vitro Activity
7%
Human Infection
7%
Cryptococcal Meningitis
7%
Core Genome multilocus Sequence Typing (cgMLST)
7%
Fonsecaea Pedrosoi
7%
Latin America (LATAM)
7%
Molecular Diagnostics
7%
Mucorales
7%
FKS1
7%
Meta-analysis
7%
Candida Haemulonii Species Complex
7%
Invasive Aspergillosis
6%
AIDS/HIV
6%
Immunology and Microbiology
Infection
100%
Infectious Disease
90%
Antifungal Susceptibility
56%
Candida
41%
Minimum Inhibitory Concentration
36%
Infectious Agent
36%
Amplified Fragment Length Polymorphism
34%
Fusarium
32%
Prevalence
30%
Sporothrix
26%
Aspergillus
25%
Real-Time Polymerase Chain Reaction
24%
In Vitro
24%
Matrix-Assisted Laser Desorption-Ionization
21%
Candida Auris
21%
Filobasidiella
20%
Molecular Epidemiology
19%
Cohort Effect
19%
Cladistics
18%
Time-of-Flight Mass Spectrometry
18%
Epidemiology
18%
Candida albicans
18%
Cryptococcus neoformans
17%
Candida parapsilosis
16%
Aspergillus fumigatus
15%
Susceptibility
15%
Aspergillosis
13%
Dermatophyte
12%
Trichosporon
12%
Genetic Variability
12%
Antifungal Resistance
12%
Lineage
12%
Type Strain
11%
Terbinafine
11%
Keratitis
10%
Penicillium
10%
Species Identification
8%
Cryptococcus gattii
8%
Polymerase Chain Reaction
8%
Wild Type
8%
Morphology
8%
Taxon
8%
New Species
8%
Chaetothyriales
8%
Mucorales
7%
Multilocus Sequence Typing
7%
Mass Spectrometry
7%
Fusarium solani
7%
Fonsecaea pedrosoi
7%
Immunocompromised Patient
7%
Mortality Rate
7%
DNA Barcoding
7%
Trichophyton rubrum
6%
Mould
6%
Filamentous Fungus
6%
Biodiversity
6%
Fungi
6%
Genome Sequencing
6%
Broth Dilution
6%
Medical Mycology
6%
Pichia
6%
Fusarium oxysporum
6%
EcoRI
5%
Ascomycota
5%
DNA Sequence
5%
Lung
5%
Next Generation Sequencing
5%
Calmodulin
5%
Medline
5%
Candida glabrata
5%
Whole Genome Sequencing
5%